01681.HK

Aug 26, 2026, 04:30 UTC

China Shineway Pharmaceutical Group Limited announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 1.785 billion, up 13.8% year-on-year, and profit attributable to shareholders of RMB 595 million, up 19.5% year-on-year.